Gürkan, E. (2023). Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. European Journal of Therapeutics, 26(1), 76–80. https://doi.org/10.5152/eurjther.2020.19005